These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9050852)

  • 1. Site-specific mutagenesis reveals differences in the structural bases for tight binding of RNase inhibitor to angiogenin and RNase A.
    Chen CZ; Shapiro R
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1761-6. PubMed ID: 9050852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot".
    Shapiro R; Ruiz-Gutierrez M; Chen CZ
    J Mol Biol; 2000 Sep; 302(2):497-519. PubMed ID: 10970748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superadditive and subadditive effects of "hot spot" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A.
    Chen CZ; Shapiro R
    Biochemistry; 1999 Jul; 38(29):9273-85. PubMed ID: 10413501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the complex of human RNase inhibitor and human eosinophil-derived neurotoxin (RNase 2).
    Teufel DP; Kao RY; Acharya KR; Shapiro R
    Biochemistry; 2003 Feb; 42(6):1451-9. PubMed ID: 12578357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
    Johnson RJ; McCoy JG; Bingman CA; Phillips GN; Raines RT
    J Mol Biol; 2007 Apr; 368(2):434-49. PubMed ID: 17350650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.
    Papageorgiou AC; Shapiro R; Acharya KR
    EMBO J; 1997 Sep; 16(17):5162-77. PubMed ID: 9311977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective abolition of pancreatic RNase binding to its inhibitor protein.
    Kumar K; Brady M; Shapiro R
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):53-8. PubMed ID: 14681553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor.
    Iyer S; Holloway DE; Kumar K; Shapiro R; Acharya KR
    J Mol Biol; 2005 Apr; 347(3):637-55. PubMed ID: 15755456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of human pancreatic ribonuclease with human ribonuclease inhibitor. Generation of inhibitor-resistant cytotoxic variants.
    Gaur D; Swaminathan S; Batra JK
    J Biol Chem; 2001 Jul; 276(27):24978-84. PubMed ID: 11342552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
    Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
    J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitor.
    Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
    Biochemistry; 1999 Aug; 38(32):10287-97. PubMed ID: 10441122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic characterization of two active mutants of placental ribonuclease inhibitor that lack internal repeats.
    Lee FS; Vallee BL
    Biochemistry; 1990 Jul; 29(28):6633-8. PubMed ID: 2397204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected binding mode for 2'-phosphoadenosine-based nucleotide inhibitors in complex with human angiogenin revealed by heteronuclear NMR spectroscopy.
    Tonan K; Xu P; Jenkins JL; Russo A; Shapiro R; Ni F
    Biochemistry; 2003 Sep; 42(38):11137-49. PubMed ID: 14503864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor.
    Lee FS; Shapiro R; Vallee BL
    Biochemistry; 1989 Jan; 28(1):225-30. PubMed ID: 2706246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraspecies regulation of ribonucleolytic activity.
    Johnson RJ; Lavis LD; Raines RT
    Biochemistry; 2007 Nov; 46(45):13131-40. PubMed ID: 17956129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural features that determine the enzymatic potency and specificity of human angiogenin: threonine-80 and residues 58-70 and 116-123.
    Shapiro R
    Biochemistry; 1998 May; 37(19):6847-56. PubMed ID: 9578571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.
    Kobe B; Deisenhofer J
    J Mol Biol; 1996 Dec; 264(5):1028-43. PubMed ID: 9000628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-oxidative effect of ribonuclease inhibitor by site-directed mutagenesis and expression in Pichia pastoris].
    Wu Y; Zhao BC; Wang JH; Zhao P; Wu YN; Cui XY
    Yi Chuan; 2005 Mar; 27(2):249-54. PubMed ID: 15843355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribonuclease A variants with potent cytotoxic activity.
    Leland PA; Schultz LW; Kim BM; Raines RT
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10407-12. PubMed ID: 9724716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.